Home ROVI signs a co-operation agreement for a clinical trial to study the efficacy and safety of bemiparin in patients hospitalised with pneumonia caused by COVID-19

ROVI signs a co-operation agreement for a clinical trial to study the efficacy and safety of bemiparin in patients hospitalised with pneumonia caused by COVID-19

Find out more …

FAQs
News
Contact

Tue, 14/04/2020 - 00:00

Descargar noticia

Download PDF
 

Comments

Add new comment

More information about text formats

Comment User

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Related News
20/10/2020
ROVI holds its 2020 General Shareholders' Meeting

ROVI increases operating income by 26% and net profit by 119% in 2

25/09/2020
ROVI Rating ESG 2020
27/07/2020
First half 2020 results presentation